GSK plc Files 6-K on AnaptysBio Inc. Litigation Update
Ticker: GSK · Form: 6-K · Filed: Apr 27, 2026 · CIK: 0001131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GSK) |
| Form Type | 6-K |
| Filed Date | Apr 27, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: litigation, legal-update, foreign-issuer
Related Tickers: ANAB
TL;DR
GSK filed a 6-K on 4/27/26 with an update on AnaptysBio Inc. litigation.
AI Summary
GSK plc filed a 6-K report on April 27, 2026, providing an update on litigation involving AnaptysBio Inc. The filing details a specific legal matter concerning AnaptysBio Inc., though the exact nature of the update and any financial implications are not specified in the provided text.
Why It Matters
This filing signals ongoing legal proceedings that could potentially impact AnaptysBio Inc.'s operations or financial standing, and by extension, GSK's involvement or interests.
Risk Assessment
Risk Level: low — The filing is a routine update on litigation and does not contain immediate financial disclosures or significant operational changes.
Key Players & Entities
- GSK plc (company) — Filer of the 6-K report
- AnaptysBio Inc. (company) — Subject of the litigation update
- 0001131399 (company) — CIK number for GSK plc
- 0001654954-26-003940 (other) — SEC Accession Number for the filing
- 2026-04-27 (date) — Filing date and period of report
FAQ
What is the specific nature of the AnaptysBio Inc. litigation update provided by GSK plc?
The provided text states that the 6-K filing contains an 'UPDATE ON ANAPTYSBIO INC. LITIGATION' but does not specify the details of the update.
When was this 6-K filing made by GSK plc?
The filing date and period of report is April 27, 2026.
What is GSK plc's CIK number?
GSK plc's CIK number is 0001131399.
What is the SEC Accession Number for this filing?
The SEC Accession Number for this filing is 0001654954-26-003940.
Does the filing mention any financial amounts related to the litigation?
The provided text does not mention any specific dollar amounts related to the litigation.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 27, 2026 regarding GSK plc (GSK).